June 29, 2022
Life Sciences
  • A group of 100 federal lawmakers is urging the Biden administration to use controversial provisions of federal law to lower prescription drug prices. The lawmakers sent a letter to HHS Secretary Xavier Becerra to discuss the issue, reiterating calls for the administration to invoke either march-in rights or another federal law known as Section 1498. Both approaches allow the federal government to sidestep patents and have been championed by academics and advocacy groups, but the administration has not pursued either tactic amid pushback from the pharmaceutical industry. (Article here)